Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Differential electrophysiological changes in striatal output neurons in Huntington's disease.

André VM, Cepeda C, Fisher YE, Huynh M, Bardakjian N, Singh S, Yang XW, Levine MS.

J Neurosci. 2011 Jan 26;31(4):1170-82. doi: 10.1523/JNEUROSCI.3539-10.2011.

2.

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease.

Galvan L, André VM, Wang EA, Cepeda C, Levine MS.

J Huntingtons Dis. 2012;1(1):17-25. doi: 10.3233/JHD-2012-120009. Review.

3.

The role of dopamine in Huntington's disease.

Cepeda C, Murphy KP, Parent M, Levine MS.

Prog Brain Res. 2014;211:235-54. doi: 10.1016/B978-0-444-63425-2.00010-6. Review.

4.

DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes?

White FJ, Hu XT, Zhang XF.

Nihon Shinkei Seishin Yakurigaku Zasshi. 1997 Apr;17(2):91-5. Review.

PMID:
9201729
5.

Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission.

Calabresi P, Pisani A, Centonze D, Bernardi G.

Nihon Shinkei Seishin Yakurigaku Zasshi. 1997 Apr;17(2):101-4. Review.

PMID:
9201731
6.

Reappraising striatal D1- and D2-neurons in reward and aversion.

Soares-Cunha C, Coimbra B, Sousa N, Rodrigues AJ.

Neurosci Biobehav Rev. 2016 Sep;68:370-386. doi: 10.1016/j.neubiorev.2016.05.021. Epub 2016 May 24. Review.

PMID:
27235078
7.

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Cepeda C, Cummings DM, André VM, Holley SM, Levine MS.

ASN Neuro. 2010 Apr 7;2(2):e00033. doi: 10.1042/AN20090058. Review.

8.

Dopamine and glutamate in Huntington's disease: A balancing act.

André VM, Cepeda C, Levine MS.

CNS Neurosci Ther. 2010 Jun;16(3):163-78. doi: 10.1111/j.1755-5949.2010.00134.x. Epub 2010 Apr 8. Review.

9.

Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Rangel-Barajas C, Rebec GV.

J Huntingtons Dis. 2016 Dec 15;5(4):303-331. Review.

10.

Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse.

Cahill E, Salery M, Vanhoutte P, Caboche J.

Front Pharmacol. 2014 Jan 8;4:172. doi: 10.3389/fphar.2013.00172. Review.

11.

The role of dopamine and glutamate modulation in Huntington disease.

Mittal SK, Eddy C.

Behav Neurol. 2013;26(4):255-63. doi: 10.3233/BEN-2012-120268. Review.

12.

Corticostriatal Dysfunction in Huntington's Disease: The Basics.

Bunner KD, Rebec GV.

Front Hum Neurosci. 2016 Jun 28;10:317. doi: 10.3389/fnhum.2016.00317. eCollection 2016. Review.

13.

Functional implications of dopamine D1 vs. D2 receptors: A 'prepare and select' model of the striatal direct vs. indirect pathways.

Keeler JF, Pretsell DO, Robbins TW.

Neuroscience. 2014 Dec 12;282:156-75. doi: 10.1016/j.neuroscience.2014.07.021. Epub 2014 Jul 22. Review.

Supplemental Content

Support Center